Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer
Patients were selected from the observational BiOCURA study in which patients were enrolled between 2009 and 2015. Serum samples from selected subjects were measured on three targeted LC-MS platforms,
